Adamis Pharmaceuticals Corp (ADMP)

[frankyahoo]

Here's the link to the trial website.

https://clinicaltrials.gov/ct2/show/NCT04729595?term=A+Phase+2%2F3%2C+Adaptive%2C+Randomized%2C+Double-Blind%2C+Placebo-Controlled+Study+to+Examine+the+Effects+of+Tempol+%28MBM-02%29+on+Preventing+COVID-19+Related+Hospitalization+in+Subjects+with+COVID-19+Infection&draw=2&rank=1

Phase 2/3 Adaptive, Randomized, Double-blind, placebo-controlled enrolling high risk subjects with early COVID19 infection with a primary endpoint of limiting hospitalization.

"As part of the initial phase 2 portion of the study, 60 COVID positive subjects with comorbidities will be enrolled. Eligible subjects positively diagnosed COVID-19 infection will be randomized 1:1 to receive either Tempol or placebo."



"Official Title: A Phase 2/3, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study to Examine the Effects of Tempol (MBM-02) on Preventing COVID-19 Related Hospitalization in Subjects With COVID-19 Infection

Estimated Study Start Date : May 1, 2021
Estimated Primary Completion Date : December 30, 2021
Estimated Study Completion Date : January 30, 2022"

They'll come out earlier than 12/30/2021 to report any positive results I would think. GLTA

$ADMP